Table 1: DNA mutations of the patient.

Gene DNA mutation Amino acid mutation Genetic background Heterozygosis/Homozygous Inheritance mode Protein structure prediction
SERPINA10 c.473A > T p.L158Q Maternal Heterozygosis AD Impairment
TGFBR2 c.944C > T p.T315M Paternal Heterozygosis AD Impairment
VIPAS39 c.1274C > A p.R425L Maternal Heterozygosis AR Impairment
NODAL c.607C > T p.E203K Paternal Heterozygosis AD Impairment
ATL3 c.713A > C p.V238G Paternal Heterozygosis AD Impairment
BRCA2 c.5785A > G p.I1929V Paternal Heterozygosis AD Impairment
JAG1 c.133C > A p.V45L Paternal Heterozygosis AD Impairment
LAMA2 c.6206A > G p.Y2069C Paternal Heterozygosis AR Impairment
ANKRD26 c.4487A > T p.V1496D Maternal Heterozygosis AD Impairment
ATXN2 IVS5-3G > A Paternal Heterozygosis AD
ABCG5 c.1528G > T p.H510N Maternal Heterozygosis AR Impairment
HMGCL c.348C > T p.A116A Maternal Heterozygosis AR Impairment
TTN c.16757C > T p.C5586Y Paternal Heterozygosis AD Impairment
SYNE1 c.13511C > A p.C4504F Maternal Heterozygosis AD Impairment
COLQ c.1228G > A p.R410W de novo Heterozygosis AR Impairment
FGFR2 c.755G > C p.S252W de novo Heterozygosis AD Impairment
KANSL1 c.271G > A p.P91S de novo Heterozygosis AD Innocuous
c.584C > A p.G195V de novo Heterozygosis AD